Literature DB >> 24316228

The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.

Emi Adachi1, Asako Kosaka1, Kohei Tsuji1, Chiharu Mizuguchi1, Hiroyuki Kawashima2, Akira Shigenaga1, Kohjiro Nagao1, Kenichi Akaji2, Akira Otaka1, Hiroyuki Saito3.   

Abstract

The N-terminal 1-83 residues of apolipoprotein A-I (apoA-I) have a strong propensity to form amyloid fibrils, in which the 46-59 segment was reported to aggregate to form amyloid-like fibrils. In this study, we demonstrated that a fragment peptide comprising the extreme N-terminal 1-43 residues strongly forms amyloid fibrils with a transition to β-sheet-rich structure, and that the G26R point mutation enhances the fibril formation of this segment. Our results suggest that in addition to the 46-59 segment, the extreme N-terminal region plays a crucial role in the development of amyloid fibrils by the N-terminal fragment of amyloidogenic apoA-I variants.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AFM; ATR; Amyloid fibril; Apolipoprotein A-I; FTIR; HDL; Peptide; Point mutation; ThT; WMF; apoA-I; apolipoprotein A-I; atomic force microscopy; attenuated total reflection; fourier transform infrared spectroscopy; high-density lipoprotein; thioflavinT; wavelength of maximum fluorescence

Mesh:

Substances:

Year:  2013        PMID: 24316228     DOI: 10.1016/j.febslet.2013.11.031

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

2.  Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I.

Authors:  Jitka Petrlova; Arnab Bhattacherjee; Wouter Boomsma; Stefan Wallin; Jens O Lagerstedt; Anders Irbäck
Journal:  Protein Sci       Date:  2014-08-23       Impact factor: 6.725

Review 3.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.

Authors:  Chiharu Mizuguchi; Miho Nakagawa; Norihiro Namba; Misae Sakai; Naoko Kurimitsu; Ayane Suzuki; Kaho Fujita; Sayaka Horiuchi; Teruhiko Baba; Takashi Ohgita; Kazuchika Nishitsuji; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

5.  Membrane effects of N-terminal fragment of apolipoprotein A-I: a fluorescent probe study.

Authors:  Valeriya Trusova; Galyna Gorbenko; Mykhailo Girych; Emi Adachi; Chiharu Mizuguchi; Rohit Sood; Paavo Kinnunen; Hiroyuki Saito
Journal:  J Fluoresc       Date:  2015-01-18       Impact factor: 2.217

6.  Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?

Authors:  Madhurima Das; Christopher J Wilson; Xiaohu Mei; Thomas E Wales; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2015-11-10       Impact factor: 5.469

7.  Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.

Authors:  Madhurima Das; Xiaohu Mei; Shobini Jayaraman; David Atkinson; Olga Gursky
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

Review 8.  Apolipoprotein A-I: A Molecule of Diverse Function.

Authors:  Manaswini Mangaraj; Rachita Nanda; Suchismita Panda
Journal:  Indian J Clin Biochem       Date:  2015-07-16

9.  Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies.

Authors:  Hitoshi Kimura; Shiho Mikawa; Chiharu Mizuguchi; Yuki Horie; Izumi Morita; Hiroyuki Oyama; Takashi Ohgita; Kazuchika Nishitsuji; Atsuko Takeuchi; Sissel Lund-Katz; Kenichi Akaji; Norihiro Kobayashi; Hiroyuki Saito
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

10.  Amyloidogenic propensity of a natural variant of human apolipoprotein A-I: stability and interaction with ligands.

Authors:  Silvana A Rosú; Omar J Rimoldi; Eduardo D Prieto; Lucrecia M Curto; José M Delfino; Nahuel A Ramella; M Alejandra Tricerri
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.